Introduction
At birth, the mouse uterus is composed of undifferentiated mesenchyme connective tissue and simple columnar epithelial cells lining a uterine lumen (Brody & Cunha, 1989) . During the first 7 days of neonatal development the endometrium and the myometrium differentiate from the mesen¬ chyme. The initiation of uterine gland formation is signalled by the invagination of the uterine epithelium into the developing connective tissue stroma (Brody & Cunha, 1989) . In rats, this pro¬ cess begins during the second week after birth and uterine glands extending to the myometrium are present by Days 10-14 (Branham et ai, 1985) .
Endogenous oestrogen is critical for initiation of normal postnatal uterine growth and differen¬ tiation. Neonatal ovariectomy (Baker & Kragt, 1969; Sheehan et ai, 1981) or the use of specific antiserum to oestradiol-17ß (Reiter et ai, 1972) prevents formation of uterine glands. Endogenous ovarian oestrogen production in rats does not begin until about neonatal Day 9 (Dohler & Wuttke, 1975) . This is followed by increased oestrogen receptor concentrations and increased competence to respond to exogenous oestrogens (Somjen et ai, 1973) .
Neonatal tissue is an excellent system in which to investigate the action of prenatal exposure to oestrogen on cell differentiation and organ development. Alterations in the ontogeny of uterine glands in rats have been reported following neonatal exposure to oestradiol-17ß (Sheehan et ai, 1981; Branham et ai, 1985) , anti-oestrogens and diethylstilboestrol (Branham et ai, 1988a, b, c) . Although the mouse has been frequently used as an animal model to examine the effect of prenatal *Author for correspondence.
and neonatal exposure to oestrogens on the subsequent differentiation and development of the female reproductive tract (Bern et ai, 1976; McLachlan et ai, 1980; Ennis & Davies 1982) Uterine glands per uterine section. Glands were counted using the criteria of Branham et al (1985) : (i) a visible glandular lumen must be observed, (ii) the glandular lumen must be separated from the uterine lumen by connective tissue and (iii) epithelial cells must line the glandular lumen. The number of uterine glands per tissue section represents an average of counts since the number of glands in the proximal, middle or distal portions of the uterus does not differ significantly (Branham et al, 1985) .
Epithelial cell height. Measurements were obtained with the use of a calibrated eyepiece micrometer and 100 magnification and converted and reported in pm.
Statistical analysis. All quantitative experimental data were compared with control values and differences analysed by using Student's t test for significant differences between individual groups. Differences were considered statistically significant at < 001.
Results

Uterine morphology
At birth, the mouse uterus is relatively immature consisting of a lumen lined by simple columnar epithelial cells and differentiating mesenchyme connective tissue. The mesenchyme was broadly separated into three structurally distinct layers. By neonatal Day 4 the inner mesenchyme layer laying adjacent to the epithelial layer had developed into the endometrial connective tissue stroma (Fig. 1) . The inner circular and outer longitudinal layers of the myometrium differentiated from the middle and outer mesenchyme. No pronounced changes in this morphology were observed during the first 4 days of development in control animals (Fig. 1) . Invagination of the luminal epithelium into the differentiating endometrial connective tissue stroma was the initial sign of uterine gland formation (Fig. 2) . This activity was first observed in control animals on Day 5 but occurred 24 h earlier in treated animals on Day 4 (Fig. 2) . The treated animals seemed to have a greater degree of invagination along the length of the epithelial layer although this aspect was not quantified. Following the initial invagination of the luminal epithelium, uterine glands in cross section were observed within the superficial endometrium (Fig. 3) . The developing uterine glands consisted of a simple columnar epithelium and were initially localized to the superficial connective tissue stroma. These glands were seen in cross section ap¬ proximately 24 h after the initial invagination of the epithelial layer was observed. Thus, uterine glands appeared earlier in diethylstilboestrol-treated animals (Day 5) than in control animals (Day 6). There were more uterine glands in experimental than in control animals (Fig. 4) .
By postnatal Day 7, uterine glands were seen in cross section lying deep in the endometrium adjacent to the myometrium in diethylstilboestrol-treated animals (Fig. 5) 
Discussion
Our results demonstrate that a single exposure to diethylstilboestrol in utero on Day 16 of gestation caused alterations in the normal differentiation of mouse uterus during the first 7 days of neonatal development. We observed transplacental stimulation by diethylstilboestrol, as hypertrophy of the endometrial epithelium at birth and premature development of uterine glands. This type of alteration has also been observed in guinea-pigs after prenatal exposure to diethylstilboestrol (Davies et ai, 1986) . There are several possible mechanisms by which diethylstilboestrol may enhance uterine differentiation.
Our results showed that, at birth, the mouse uterus is composed of undifferentiated mesen¬ chyme connective tissue and simple columnar epithelial cells lining the uterine lumen. These results are similar to those of Brody & Cunha (1989) . By neonatal Day 4, the endometrium and the myometrium have differentiated from the mesenchyme. Earlier reports, using steroid autoradiography, demonstrated that both diethylstilboestrol (Stumpfe/ ai, 1980) and oestradiol-17ß (Cunha et ai, 1982) bind to oestrogen receptors localized in nuclei of mesenchyme cells but not in the epithelial cells. However, morphogenesis and DNA synthesis was stimulated within the epithelial cell population in the neonate by endogenous oestrogens (Eide, 1975) and diethylstilboestrol (Bigsby & Cunha, 1986) . These paradoxical results were explained by the hypothesis that stromal cells produced a growth regulatory factor which acted on the epithelial cell population (Bigsby & Cunha, 1986) . However, later reports have indicated that oestrogen receptor proteins may be present in the epithelial cell population but below the limits of detection and sensitivity of steroid autoradiography. Korach et ai (1988) have demonstrated oestrogen receptor protein in the epithelial and stromal cell fractions from 5-Day mouse uteri using SDS-polyacrylamide gel electrophoresis and Western Blot methods.
A second possible mechanism of action of diethylstilboestrol may be through altered ovarian development via the hypothalamo-hypophyseal system and not through direct action on uterine cells. The prenatal exposure of mice to diethylstilboestrol profoundly alters ovarian structure and function in neonatal and adult female progeny (Wordinger & Highman, 1984; Wordinger & Derrenbacker, 1989) . Follicle maturation was advanced, mature follicles appearing during the first 7 days of neonatal development in diethylstilboestrol-exposed animals. It was suggested that di¬ ethylstilboestrol decreased the transit time between the various stages of follicle development by influencing the hypothalamo-hypophyseal axis. At birth, diethylstilboestrol-exposed progeny had significantly more Type 3a ovarian follicles, and Types 3b and 4 follicles appeared earlier than in control progeny. On Day 5 of neonatal ovarian development, a burst of ovarian follicular devel¬ opment has been reported (Wordinger & Derrenbacker, 1989) . Type 4 ovarian follicles with a developing theca interna are present as well as increased angiogenesis within the ovarian stroma.
It may be significant that the increase in ovarian follicle activity coincides in diethylstilboestrolexposed animals with the initial appearance of uterine glands. These morphological changes may signal altered endogenous ovarian steroid production which might influence uterine gland forma¬ tion. The presence of follicles with a theca interna during the first week of life in diethylstilboestrolexposed animals may alter the endocrine profile by increasing oestrogen concentrations which could have a secondary effect on the immature reproductive tract. The concentration of endo¬ genous oestrogen produced could be higher and consequently not totally bound by circulating serum a-foetoprotein thus becoming available to the target mesenchyme cells. Korach et al. (1988) demonstrated that oestrogen receptor protein expression is increased by treatment with diethyl¬ stilboestrol. This would provide a mechanism by which the oestrogen receptor would be present in epithelial cells prematurely and the continued exposure of foetal or neonatal tissues to endogenous or exogenous oestrogens would result in prolonged oestrogen stimulation and subsequent toxicity of the reproductive tract.
In conclusion, we have demonstrated a transplacental effect of diethylstilboestrol on the developing uterus. Prenatal exposure to diethylstilboestrol caused uterine epithelial cell hyper¬ trophy at birth and the premature formation of uterine glands. The mechanism of action of diethyl¬ stilboestrol is unresolved, but may involve direct stimulation via oestrogen receptors, secondary stimulation via uterine-specific growth regulatory factors or an alteration in ovarian development leading to altered concentrations of endogenous oestrogens.
